Egbuonu-Davis Lisa sold $24K of PHR
Egbuonu-Davis Lisa sold 2,546 shares of Phreesia, Inc. (PHR) at $9.53 on 2026-06-25 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider’s holdings (38,316 shares after sale) but does not introduce new company-specific fundamentals.
Market read
Traders may note the insider sale, but the pre-arranged nature and modest value suggest limited trading edge.
What to watch
The transaction is explicitly under a pre-arranged 10b5-1 plan, which reduces interpretability as a directional signal.
Background
SEC Form 4 insider transaction for Phreesia, Inc. (PHR) reported by a director.
Ticker impact
Phreesia director Egbuonu-Davis Lisa sold 2,546 shares in an open-market transaction for about $24.3K under a pre-arranged 10b5-1 plan.
Minimal near-term impact; any effect is likely short-lived and outweighed by normal trading noise.
The filing is a small, pre-planned 10b5-1 open-market sale by a director, with no accompanying new operational or financial catalyst.
Market effects
No meaningful sector read-through; this is a single-company insider transaction.
None.
None.
Counterpoint
Even 10b5-1 sales can coincide with private information, so some traders may treat the sale as a mild caution signal.
Key entities
- issuerPhreesia, Inc.
Subject of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.
- insiderEgbuonu-Davis Lisa
Director who executed an open-market sale of 2,546 shares on 2026-06-25.
